Skip Header

You are using a version of Internet Explorer that may not display all features of this website. Please upgrade to a modern browser.
Contribute Send feedback
Read comments (?) or add your own

Q6UVH2 (Q6UVH2_HUMAN) Unreviewed, UniProtKB/TrEMBL

Last modified July 9, 2014. Version 60. Feed History...

Clusters with 100%, 90%, 50% identity | Third-party data text xml rdf/xml gff fasta
to top of pageNames·Attributes·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry infoCustomize order

Names and origin

Protein attributes

Sequence length148 AA.
Sequence statusFragment.
Protein existencePredicted

Ontologies

Gene Ontology (GO)
   Biological_processG-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger

Inferred from electronic annotation. Source: Ensembl

aldosterone secretion

Inferred from electronic annotation. Source: Ensembl

behavior

Inferred from electronic annotation. Source: Ensembl

brain renin-angiotensin system

Inferred from electronic annotation. Source: Ensembl

cell growth involved in cardiac muscle cell development

Inferred from electronic annotation. Source: Ensembl

cellular response to dexamethasone stimulus

Inferred from electronic annotation. Source: Ensembl

cellular sodium ion homeostasis

Inferred from electronic annotation. Source: Ensembl

cerebellar cortex development

Inferred from electronic annotation. Source: Ensembl

dopamine biosynthetic process

Inferred from electronic annotation. Source: Ensembl

inflammatory response

Inferred from electronic annotation. Source: Ensembl

negative regulation of fibroblast proliferation

Inferred from electronic annotation. Source: Ensembl

negative regulation of heart rate

Inferred from electronic annotation. Source: Ensembl

negative regulation of icosanoid secretion

Inferred from electronic annotation. Source: Ensembl

negative regulation of norepinephrine secretion

Inferred from electronic annotation. Source: Ensembl

positive regulation of branching involved in ureteric bud morphogenesis

Inferred from electronic annotation. Source: Ensembl

positive regulation of cell proliferation

Inferred from electronic annotation. Source: Ensembl

positive regulation of cytokine secretion

Inferred from electronic annotation. Source: Ensembl

positive regulation of metanephric glomerulus development

Inferred from electronic annotation. Source: Ensembl

positive regulation of nitric-oxide synthase activity

Inferred from electronic annotation. Source: Ensembl

positive regulation of renal sodium excretion

Inferred from electronic annotation. Source: Ensembl

positive regulation of transcription, DNA-templated

Inferred from electronic annotation. Source: Ensembl

positive regulation of vasodilation

Inferred from electronic annotation. Source: Ensembl

regulation of apoptotic process

Inferred from electronic annotation. Source: InterPro

regulation of metanephros size

Inferred from electronic annotation. Source: Ensembl

regulation of systemic arterial blood pressure by circulatory renin-angiotensin

Inferred from electronic annotation. Source: Ensembl

regulation of transcription factor import into nucleus

Inferred from electronic annotation. Source: Ensembl

renin-angiotensin regulation of aldosterone production

Inferred from electronic annotation. Source: Ensembl

response to organonitrogen compound

Inferred from electronic annotation. Source: Ensembl

vasodilation by angiotensin involved in regulation of systemic arterial blood pressure

Inferred from electronic annotation. Source: Ensembl

   Cellular_componentintegral component of membrane

Inferred from electronic annotation. Source: InterPro

perinuclear region of cytoplasm

Inferred from electronic annotation. Source: Ensembl

plasma membrane

Inferred from electronic annotation. Source: Ensembl

   Molecular_functionangiotensin type II receptor activity

Inferred from electronic annotation. Source: Ensembl

peptide hormone binding

Inferred from electronic annotation. Source: Ensembl

Complete GO annotation...

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Experimental info

Non-terminal residue11 EMBL AAQ62073.1
Non-terminal residue1481 EMBL AAQ62073.1

Sequences

Sequence LengthMass (Da)Tools
Q6UVH2 [UniParc].

Last modified July 5, 2004. Version 1.
Checksum: 76DA6142BE8E014B

FASTA14816,983
        10         20         30         40         50         60 
YQSVIYPFLS QRRNPWQASY IVPLVWCMAC LSSLPTFYFR DVRTIEYLGV NACIMAFPPE 

        70         80         90        100        110        120 
KYAQWSAGIA LMKNILGFII PLIFIATCYF GIRKHLLKTN SYGKNRITRD QVLKMAAAVV 

       130        140 
LAFIICWLPF HVLTFLDALA WMGVINSC 

« Hide

References

[1]"Partial sequence of the AGTR2 gene in Cantonese."
Zhang M., Wang B., Zhao Y.
Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE.

Cross-references

Sequence databases

EMBL
GenBank
DDBJ
AH013177 Genomic DNA. Translation: AAQ62073.1.

3D structure databases

ProteinModelPortalQ6UVH2.
ModBaseSearch...
MobiDBSearch...

Protocols and materials databases

StructuralBiologyKnowledgebaseSearch...

Gene expression databases

ArrayExpressQ6UVH2.
BgeeQ6UVH2.

Family and domain databases

Gene3D1.20.1070.10. 1 hit.
InterProIPR000147. ATII_AT2_rcpt.
IPR000248. ATII_rcpt.
IPR000276. GPCR_Rhodpsn.
IPR017452. GPCR_Rhodpsn_7TM.
[Graphical view]
PfamPF00001. 7tm_1. 1 hit.
[Graphical view]
PRINTSPR00241. ANGIOTENSINR.
PR00636. ANGIOTENSN2R.
PR00237. GPCRRHODOPSN.
PROSITEPS50262. G_PROTEIN_RECEP_F1_2. 1 hit.
[Graphical view]
ProtoNetSearch...

Entry information

Entry nameQ6UVH2_HUMAN
AccessionPrimary (citable) accession number: Q6UVH2
Entry history
Integrated into UniProtKB/TrEMBL: July 5, 2004
Last sequence update: July 5, 2004
Last modified: July 9, 2014
This is version 60 of the entry and version 1 of the sequence. [Complete history]
Entry statusUnreviewed (UniProtKB/TrEMBL)
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.